Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 12 , ISSUE 4 ( October-December, 2023 ) > List of Articles

Original Article

Effectiveness of Chemical Pleurodesis Using Doxycycline in Malignant and Nonmalignant Pleural Disorders: A Retrospective Study from Rural South India

Bimal Raj Rajalingam, Priya R Panicker, Archana L Peethambaran, Alexander Jenish Babu, Ravichandran Vijayakumar

Keywords : Doxycycline, Effectiveness, Malignant, Nonmalignant, Pleurodesis

Citation Information : Rajalingam BR, Panicker PR, Peethambaran AL, Babu AJ, Vijayakumar R. Effectiveness of Chemical Pleurodesis Using Doxycycline in Malignant and Nonmalignant Pleural Disorders: A Retrospective Study from Rural South India. Indian J Respir Care 2023; 12 (4):299-302.

DOI: 10.5005/jp-journals-11010-1070

License: CC BY-NC-SA 4.0

Published Online: 18-01-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Background: Chemical pleurodesis is an important tool in the management of refractory pleural effusion. Although talc is widely used as a sclerosing agent of choice, alternative agents like doxycycline have emerged as cheaper and safer agents for chemical pleurodesis. Objective: The aim was to evaluate the effectiveness and clinical outcomes of chemical pleurodesis using doxycycline (500 mg single dose) in the treatment of malignant and nonmalignant pleural effusion and recurrent pneumothorax. Materials and methods: A total of 36 patients, of which 23 patients with malignant pleural effusion, nine patients with pneumothorax, and four patients with nonmalignant effusion, were included in the analysis. After intercostal drainage (ICD) of air or fluid, xylocaine was instilled for pleural anesthesia, and 500 mg of doxycycline was used as a sclerosant. Successful pleurodesis was defined as expanded lung with close approximation between visceral and parietal pleura and minimal to no effusion or pneumothorax at 2 weeks. Results: At the end of 2 weeks, all 23 patients with malignant pleural effusion and nine patients with refractory pneumothorax had successful pleurodesis, but four patients with hepatic hydrothorax had no response. The most common adverse events with pleurodesis included chest pain and fever. Conclusion and clinical significance: Doxycycline was found to be a safe and effective agent for chemical pleurodesis in patients with malignant pleural effusions and recurrent pneumothorax. However, the outcome of hepatic hydrothorax remained unsatisfactory.

PDF Share
  1. Ali M, Surani S. Pleurodesis. Stat Pearls; 2022.
  2. Mierzejewski M, Korczynski P, Krenke R, et al. Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration. Respir Res 2019;20(1):247. DOI: 10.1186/s12931-019-1204-x
  3. Yeung M, Loh EW, Tiong TY, et al. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Clin Exp Metastasis 2020;37(4):541–549. DOI: 10.1007/s10585-020-10042-2
  4. Chan JYH, Lee YCG. Pleurodesis and systemic inflammatory markers: lessons and insights. Respirology 2020;25(7):676–677. DOI: 10.1111/resp.13765
  5. Hatata EM, Daabis RG, El Sabaa M, et al. Doxycycline poudrage: an old agent for a new technique. Egypt J Chest Dis Tuberc 2017;66(2):331–338. DOI: 10.1016/j.ejcdt.2016.08.012
  6. Tettey M, Sereboe L, Edwin F, et al. Tetracycline pleurodesis for malignant pleural effusion-a review of 38 cases. Ghana Med J 2005;39(4):128–131.
  7. Aydin Y, Turkyilmaz A, Intepe YS, et al. Malignant pleural effusions: appropriate treatment approaches. Eurasian J Med 2009;41(3):186–193. PMID: 25610100.
  8. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58(Suppl 2):ii29–ii38. DOI: 10.1136/thorax.58.suppl_2.ii29
  9. Hemmati HR, Hadjizadeh A, Malek F, et al. Comparison of the effects of doxycycline and povidone iodine in treatment of pleural effusion; an open label randomized clinical trial. Immunopathol Persa 2022;e13186. DOI: 10.34172/ipp.2022.13186
  10. Baranitharan M, Kumar PVS, Suraj KP, et al. A prospective study comparing talc and tetracycline pleurodesis in pneumothorax. Int J Health Sci Res 2015;5(7):50–57.
  11. Xia H, Wang XJ, Zhou Q, et al. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One 2014;9(1):e87060. DOI: 10.1371/journal.pone.0087060
  12. Wang L, Deng H, Chen X, et al. Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials. World J Surg Oncol 2020;18(1):184. DOI: 10.1186/s12957-020-01940-6
  13. Lee WJ, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. Korean J Hepatol 2011;17(4): 292–298. DOI: 10.3350/kjhep.2011.17.4.292
  14. Yuvarajan S, Radhakrishnan P, Selvam AM, et al. Role of indwelling pleural catheters in achieving spontaneous pleurodesis in hepatic hydrothorax - pioneer retrospective study from a tertiary care centre, India. European Resp J 2020;56(Suppl 64):1588. DOI: 10.1183/13993003.congress-2020.1588
  15. DiBardino DJ, Vanatta JM, Fagan SP, et al. Acute respiratory failure after pleurodesis with doxycycline. Ann Thorac Surg 2002;74(1):257–258. DOI: 10.1016/s0003-4975(01)03518-4
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.